Clark Capital Management Group, Inc. Ligand Pharmaceuticals Inc Transaction History
Clark Capital Management Group, Inc.
- $13.4 Billion
- Q1 2025
A detailed history of Clark Capital Management Group, Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 44,054 shares of LGND stock, worth $5.8 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
44,054
Previous 37,277
18.18%
Holding current value
$5.8 Million
Previous $3.99 Million
15.95%
% of portfolio
0.03%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding LGND
# of Institutions
280Shares Held
19MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$378 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$270 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$135 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$119 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$98 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.22B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...